Cite
Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation
MLA
Live Dengue Vaccines Technical Consultation Reporting Group, et al. “Long-Term Safety Assessment of Live Attenuated Tetravalent Dengue Vaccines: Deliberations from a WHO Technical Consultation.” Vaccine, vol. 31, no. 23, May 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....63be717e63ed3954a0c86b4f9559e1a2&authtype=sso&custid=ns315887.
APA
Live Dengue Vaccines Technical Consultation Reporting Group, Bentsi-Enchill, A. D., Schmitz, J., Edelman, R., Durbin, A., Roehrig, J. T., Smith, P. G., Hombach, J., & Farrar, J. (2013). Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation. Vaccine, 31(23).
Chicago
Live Dengue Vaccines Technical Consultation Reporting Group, Adwoa D Bentsi-Enchill, Julia Schmitz, Robert Edelman, Anna Durbin, John T Roehrig, Peter G Smith, Joachim Hombach, and Jeremy Farrar. 2013. “Long-Term Safety Assessment of Live Attenuated Tetravalent Dengue Vaccines: Deliberations from a WHO Technical Consultation.” Vaccine 31 (23). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....63be717e63ed3954a0c86b4f9559e1a2&authtype=sso&custid=ns315887.